Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Lessons From a Recovering Department Chair.

DeLander GE.

Am J Pharm Educ. 2017 Apr;81(3):43. doi: 10.5688/ajpe81343. No abstract available.

2.

An Interprofessional Approach to Reducing the Risk of Falls Through Enhanced Collaborative Practice.

Eckstrom E, Neal MB, Cotrell V, Casey CM, McKenzie G, Morgove MW, DeLander GE, Simonson W, Lasater K.

J Am Geriatr Soc. 2016 Aug;64(8):1701-7. doi: 10.1111/jgs.14178. Epub 2016 Jul 28.

3.

Falls prevention education: Interprofessional training to enhance collaborative practice.

McKenzie G, Lasater K, Delander GE, Neal MB, Morgove M, Eckstrom E.

Gerontol Geriatr Educ. 2017 Apr-Jun;38(2):232-243. doi: 10.1080/02701960.2015.1127809. Epub 2016 Feb 17.

PMID:
26886245
4.

Report of the AACP task force on patient-centered medical homes and accountable care organizations.

Adams AJ, Clark DR, DeLander GE, Mackinnon GE 3rd, Malloy M, McGivney MS, Mobley C, Nuffer W, Parsons P, Smesny AL, Smith M, Ives TJ.

Am J Pharm Educ. 2013 Sep 12;77(7):142. doi: 10.5688/ajpe777142. No abstract available.

5.

Opportunities and responsibilities for the academy in the medical home.

Adams AJ, Clark DR, Delander GE, Nuffer W, Smith M, Ives TJ.

Am J Pharm Educ. 2013 Sep 12;77(7):137. doi: 10.5688/ajpe777137. No abstract available.

6.

Rules of the road.

DeLander GE.

Am J Pharm Educ. 2012 Jun 18;76(5):76. doi: 10.5688/ajpe76576. No abstract available.

7.

Preparing pharmacy graduates for traditional and emerging career opportunities.

Brazeau GA, Meyer SM, Belsey M, Bednarczyk EM, Bilic S, Bullock J, DeLander GE, Fiese EF, Giroux SL, McNatty D, Nemire R, Prescott WA Jr, Traynor AP.

Am J Pharm Educ. 2009 Dec 17;73(8):157.

8.

Increased nociceptive response in mice lacking the adenosine A1 receptor.

Wu WP, Hao JX, Halldner L, Lövdahl C, DeLander GE, Wiesenfeld-Hallin Z, Fredholm BB, Xu XJ.

Pain. 2005 Feb;113(3):395-404.

PMID:
15661449
9.

Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations.

Schulte G, Robertson B, Fredholm BB, DeLander GE, Shortland P, Molander C.

Neuroscience. 2003;121(4):907-16.

PMID:
14580941
10.

Spinal expression of mRNA for immediate early genes in a model of chronic pain.

Delander GE, Schött E, Brodin E, Fredholm BB.

Acta Physiol Scand. 1997 Dec;161(4):517-25.

PMID:
9429660
11.

Temporal changes in spinal cord expression of mRNA for substance P, dynorphin and enkephalin in a model of chronic pain.

Delander GE, Schött E, Brodin E, Fredholm BB.

Acta Physiol Scand. 1997 Dec;161(4):509-16.

PMID:
9429659
12.

Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.

Choi H, Murray TF, DeLander GE, Schmidt WK, Aldrich JV.

J Med Chem. 1997 Aug 15;40(17):2733-9.

PMID:
9276018
13.

Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.

Arttamangkul S, Ishmael JE, Murray TF, Grandy DK, DeLander GE, Kieffer BL, Aldrich JV.

J Med Chem. 1997 Apr 11;40(8):1211-8.

PMID:
9111295
14.
15.

Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors.

Keil GJ 2nd, Delander GE.

J Pharmacol Exp Ther. 1995 Sep;274(3):1387-92.

PMID:
7562512
16.

Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.

Arttamangkul S, Murray TF, DeLander GE, Aldrich JV.

J Med Chem. 1995 Jun 23;38(13):2410-7.

PMID:
7608905
17.
18.

Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.

Snyder KR, Murray TF, DeLander GE, Aldrich JV.

J Med Chem. 1993 Jun 25;36(13):1921-2. No abstract available.

PMID:
8099977
19.
21.

N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors.

Choi H, Murray TF, DeLander GE, Caldwell V, Aldrich JV.

J Med Chem. 1992 Nov 27;35(24):4638-9. No abstract available.

PMID:
1361580
22.

Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity.

Snyder KR, Story SC, Heidt ME, Murray TF, DeLander GE, Aldrich JV.

J Med Chem. 1992 Nov 13;35(23):4330-3.

PMID:
1360025
23.

Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.

Story SC, Murray TF, Delander GE, Aldrich JV.

Int J Pept Protein Res. 1992 Aug;40(2):89-96.

PMID:
1359999
25.

Descending systems activated by morphine (ICV) inhibit kainic acid (IT)-induced behavior.

DeLander GE, Wahl JJ.

Pharmacol Biochem Behav. 1991 May;39(1):155-9.

PMID:
1718010
26.

Involvement of spinal adenosine in descending antinociception produced by supraspinal receptor-selective opioid agonists.

Li ZW, DeLander GE, Porreca F.

NIDA Res Monogr. 1990;105:386-7. No abstract available.

PMID:
1876048
27.
28.

In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.

DeLander GE, Wahl JJ.

Eur J Pharmacol. 1989 Jan 10;159(2):149-56.

PMID:
2468511
29.
30.

Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception.

DeLander GE, Hopkins CJ.

Neuropharmacology. 1987 Dec;26(12):1791-4. Erratum in: Neuropharmacology 1988 Jun;27(6):1.

PMID:
3437941
31.

Involvement of A2 adenosine receptors in spinal mechanisms of antinociception.

DeLander GE, Hopkins CJ.

Eur J Pharmacol. 1987 Jul 9;139(2):215-23.

PMID:
3653244
32.

Role of the spinal cord in the development of opiate tolerance and dependence.

Takemori AE, DeLander GE, Portoghese PS.

NIDA Res Monogr. 1987;76:42-5. No abstract available.

PMID:
2830531
33.

Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine.

DeLander GE, Hopkins CJ.

J Pharmacol Exp Ther. 1986 Oct;239(1):88-93.

PMID:
2428975
34.

Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.

DeLander GE, Portoghese PS, Takemori AE.

J Pharmacol Exp Ther. 1984 Oct;231(1):91-6.

PMID:
6092607
35.

Spinal antagonism of tolerance and dependence induced by systemically administered morphine.

Delander GE, Takemori AE.

Eur J Pharmacol. 1983 Oct 14;94(1-2):35-42.

PMID:
6686142

Supplemental Content

Loading ...
Support Center